InvestorsHub Logo

axelvento

02/24/22 10:35 AM

#11048 RE: Gpheart2016 #11047


EMA recommends approval of Spikevax for children aged 6 to 11

https://www.ema.europa.eu/en/news/ema-recommends-approval-spikevax-children-aged-6-11

blanka

02/24/22 11:38 AM

#11049 RE: Gpheart2016 #11047

Never go by the penny stock messengers post

axelvento

02/24/22 11:58 AM

#11050 RE: Gpheart2016 #11047

Commercial Outlook in 2023 & Beyond

Spikevax ® 2023 commercial outlook: Moderna has received firm orders for delivery in 2023 from the United Kingdom, Canada, Taiwan, and Kuwait. The Company is currently in active discussions for additional orders in 2023.
Supply agreements with strategic countries: Moderna is committed to expanding its partnerships with governments to equip countries with access to innovative vaccines against respiratory viruses, and domestic access to rapid pandemic response capabilities. To date, Moderna has announced in principle agreements with Australia and Canada and the Company is in discussions with additional countries for similar partnerships.

FooBarAndGrill

02/24/22 6:40 PM

#11060 RE: Gpheart2016 #11047

WOW! What is that PE? 4/1?